New drug treatments for HIV infection and AIDS. A review following the Seventh International Conference on AIDS, Florence 16-21 June 1991
- PMID: 1576062
- PMCID: PMC1381291
- DOI: 10.1111/j.1365-2125.1992.tb04051.x
New drug treatments for HIV infection and AIDS. A review following the Seventh International Conference on AIDS, Florence 16-21 June 1991
Abstract
1. OBJECTIVE--To evaluate the status of clinical development of zidovudine and new drugs for the treatment of Human Immunodeficiency Virus (HIV) infections. 2. METHOD--A critical review of the clinical trial reports and assessment of the design and methodology of the therapeutic trials. Evaluation of the drugs being tested and of the specific difficulties in testing drugs in AIDS. 3. CONCLUSIONS--Drugs are being tested in a unique climate of public opinion characterised by (1) fast track criteria for regulatory approval (2) parallel track (compassionate release) of new drugs before adequate determination of safety and efficacy (3) resistance to the use of placebos in controlled trials.
Similar articles
-
[Clinical effectiveness of zidovudine].Ned Tijdschr Geneeskd. 1995 Feb 4;139(5):211-3. Ned Tijdschr Geneeskd. 1995. PMID: 7854480 Dutch. No abstract available.
-
[Zidovudine. The current status of its evaluation].Therapie. 1989 Nov-Dec;44(6):393-9. Therapie. 1989. PMID: 2696136 Review. French.
-
[Anti-HIV therapy (1987-1994): from nothing to confusion].Med Clin (Barc). 1995 Apr 1;104(12):463-7. Med Clin (Barc). 1995. PMID: 7739285 Review. Spanish. No abstract available.
-
[AIDS. 3rd European conference on the clinical aspects and treatment of HIV infection. Paris, 12-13 March 1992. 4th German AIDS congress. Wiesbaden, 25-28 March 1992. 8th International AIDS Conference. Amsterdam, 19-24 July 1992].Internist (Berl). 1992 Oct;33(10 Suppl [AIDS]):1-24. Internist (Berl). 1992. PMID: 1363472 German. No abstract available.
-
Zidovudine: a review of pharmacoeconomic and quality-of-life considerations for its use in patients with human immunodeficiency virus.Pharmacoeconomics. 1993 Apr;3(4):309-37. doi: 10.2165/00019053-199303040-00006. Pharmacoeconomics. 1993. PMID: 10146993 Review.
Cited by
-
Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin.Antimicrob Agents Chemother. 1996 Sep;40(9):2087-93. doi: 10.1128/AAC.40.9.2087. Antimicrob Agents Chemother. 1996. PMID: 8878586 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical